Announcing ZERO's New CEO
We are excited to welcome Courtney Bugler, CFRE as our new President & CEO, effective August 7, 2023. As the daughter of a prostate cancer survivor—and as a breast cancer survivor herself—Courtney's journey fuels her deep passion for our mission. Her dedication to raising awareness, securing funding, and providing vital resources stems from a genuine understanding of the urgency to combat this disease.
Courtney's personal connection to prostate cancer combined with her experience as a nonprofit leader makes her an incredible asset to ZERO. Join us as we embark on the exciting chapter with Courtney taking the lead. Together, we'll continue making a lasting impact on the fight against prostate cancer.
The Prostate Cancer Community Sees Progress with New FDA Approvals
On May 31, 2023, AstraZeneca's LYNPARZA ®, a PARP inhibitor, was approved with abiraterone and prednisone for metastatic castration resistant prostate cancer (mCRPC) patients who also have a BRCA gene mutation.
On June 2, 2023, Blue Earth Diagnostics' POSLUMA ® was approved as an injection for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions for patients with suspected prostate cancer recurrence or metastasis.
On June 20, 2023, Pfizer's TALZENNA®, in combination with XTANDI®, was approved for patients with mCRPC and a mutated homologous recombination repair (HRR) gene. TALZENNA® is a PARP inhibitor and the first of its kind for use in mCRPC patients.
These advances represent new classes of radiopharmaceuticals as well as promising targeted treatment options for patients with metastatic prostate cancer. Not only will these help providers treat prostate cancer, but they will also help find prostate cancer earlier so treatment can be more effective. None of these advances would be possible without the incredible research teams and patients who volunteer to participate in clinical trials. On behalf of the entire prostate cancer community, thank you for all that you do!
Join the Blue Ribbon Circle to Make a Year-Round Impact
A monthly gift from generous community members like you can significantly impact the lives of prostate cancer patients and families in urgent need of support. You're invited to join the Blue Ribbon Circle, ZERO's monthly donor program, to help provide consistent and vital resources each month to those who need them most. Become a member by making a monthly gift, and you'll become a hero for prostate cancer patients year-round.
Men's Health Matters Every Month
June may be over, but men's health matters every single day. We remain steadfast in our efforts to shine a spotlight on the well-being of men and understand the silent battles prostate cancer patients and their families are facing.
Take a look at some of last month's highlights; from our updated Truth or Twisted quiz to new podcast episodes, a raw and emotional blog by prostate cancer survivor, Chris Hartley, a webinar to help veterans navigate their VA benefits, our Black Men's Prostate Cancer Film Series, a Virtual Advocacy Day, MLB Prostate Cancer Awareness games, our Des Moines Tee-Off, and more. Remember: Early Detection Can Save Lives.
An Easy Way to Plan for Your Future
Next month is National Make-A-Will Month, and our partnership with FreeWill offers ZERO community members the opportunity to approach the future with peace of mind. Creating a will or trust gives you the chance to communicate your wishes, provide for your loved ones, and protect what matters to you at no cost.
While creating your plans, you can choose to establish a legacy of impact by making an optional planned gift to ZERO. As a reminder, every gift gives prostate cancer patients and their families the help and hope they need to keep going.
Thank You Katie Richardson
Twelve years ago, Katie's father was diagnosed with prostate cancer. With unwavering love, she continues to bring awareness in the hopes to find a cure.
"I want my dad to know his fight was worth it, that people care and are fighting on his behalf, and—above all—I want him to know I made a difference for him." —Katie Richardson
» Become a Champion Like Katie
Try Fun-Filled Fundraising this Summer!
Take your summer activities to the next level by turning your cherished memories into a meaningful fundraising opportunity that will make a lasting impact on the lives of prostate cancer patients. Whether you're a Frisbee golf aficionado, a corn hole champion, or an expert kite flier, you can combine your passions with a purpose, and we'll provide you with the essential tools and resources that will transform your activities into a force for good. » Build Your Fundraiser
Macrogenics Sponsoring TAMARACK Clinical Study
Are you or a loved one battling metastatic prostate cancer? You may be eligible for Macrogenics' TAMARACK clinical study, which is studying antibody-drug conjugates (ADCs) as a potential treatment.
Learn more about the TAMARACK study, which is comparing dose levels for a potential ADC treatment option for metastatic prostate cancer, and find out if you're eligible. » Learn More
This content is sponsored by MacroGenics.
Webinar: Bring Your Advocacy Home
Every year during the ZERO Summit, we visit Capitol Hill to share our stories and advocate for policy changes that will benefit prostate cancer patients and their families. But did you know that you don't have to travel to DC to make an impact?
Make your prostate cancer advocacy a year-round activity and learn from the ZERO Government Affairs team how you can schedule and hold meetings with your elected officials in your district. Join us July 27 at 2:00 p.m. ET for our advocacy webinar. » Register Now
Webinar: Engaging in Self-Advocacy
Mark your calendars for Triage Cancer's free webinar on July 26, where you'll learn about invaluable tools for self-advocacy. From practical tips on gathering medical records to effective communication with healthcare teams, navigating work while managing cancer, accessing benefits, handling appeals, and debunking inaccurate online information—this webinar will help you take control of your journey. Together with Triage Cancer, we're here to equip you with the resources you need to face cancer with confidence. » Register Now
Research Study on the Role of Genes in Treatment
Join more than 2,700 men who've already chosen to enroll in the PROMISE Registry - a free research study to learn valuable new information about how genes can impact therapeutic regimens. Participants will receive free genetic testing and counseling, insight into family members' risk of prostate cancer, and information about new prostate cancer research, clinical trials, and new FDA-approved treatment. » Join and help advance research
This content is provided in partnership with PROMISE.